Skip to main content

Table 1 The detailed characteristics of 106 patients

From: Evaluation of IL-2 and Dexamethasone intracavitary injection on the management of malignant effusion in children with solid tumors or lymphoma

 

Effusion group

Control group

Solid tumor

Lymphoma

Solid tumor

Lymphoma

Age (mean)

5.42

8.02

4.96

9.8

Gender

 Male

15

32

6

6

 Female

14

24

5

4

Stage

 II

  

1

 

 III

4

15

5

4

 IV

24

44

4

6

 IVs

  

1

 

Histology

 RMS

7

 

3

 

 NB

4

 

1

 

 PPB

3

   

 Ewing’s sarcoma

4

 

2

 

 HB

6

 

3

 

 PNET

5

 

2

 

 T cell lymphoblastic lymphoma

 

36

 

5

 B cell lymphoblastic lymphoma

 

9

 

2

 DLBCL

 

6

 

2

 BL

 

3

  

 ALCL

 

2

 

1

  1. RMS rhabdomyosarcoma, NB neuroblastoma, PPB pediatric pneumoblastoma, HB hepatoblastoma, PNET primitive neuroectodermal tumor, DLBCL diffuse large B-cell lymphoma, BL Burkitt’s lymphoma, ALCL anaplastic large cell lymphoma